Soc. Generale Discount Zert PBB 2.../ DE000SV9KEM9 /
| 2024-06-03 1:12:55 PM | Chg.0.00 | Bid2024-06-03 | Ask2024-06-03 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 4.94EUR | 0.00% | 4.94 Bid Size: 6,000 |
- Ask Size: - |
DT.PFANDBRIEFBK AG | - EUR | 2024-06-28 | Call |
GlobeNewswire
2:20 PM
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
2:15 PM
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
2:14 PM
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
2:10 PM
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
2:07 PM
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
2:05 PM
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
2:04 PM
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
2:02 PM
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
GlobeNewswire
2:01 PM
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
2:00 PM
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
2:00 PM
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
2:00 PM
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...
